Display Settings:

Format
Sort by

Send to:

Choose Destination
We are sorry, but NCBI web applications do not support your browser and may not function properly. More information

    Results: 2

    1.

    EDSS variability before randomization may limit treatment discovery in primary progressive MS.

    Zhang J, Waubant E, Cutter G, Wolinsky JS, Glanzman R.

    Mult Scler. 2013 May;19(6):775-81. doi: 10.1177/1352458512459685. Epub 2012 Oct 1.

    PMID:
    23027880
    [PubMed - in process]
    2.

    Rituximab in patients with primary progressive multiple sclerosis: results of a randomized double-blind placebo-controlled multicenter trial.

    Hawker K, O'Connor P, Freedman MS, Calabresi PA, Antel J, Simon J, Hauser S, Waubant E, Vollmer T, Panitch H, Zhang J, Chin P, Smith CH; OLYMPUS trial group.

    Ann Neurol. 2009 Oct;66(4):460-71. doi: 10.1002/ana.21867.

    PMID:
    19847908
    [PubMed - indexed for MEDLINE]

      Supplemental Content

      Find related data

      Search details

      See more...

      Recent activity

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      Write to the Help Desk